Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Agnes J. Staal-van den Brekel"'
Autor:
Magdolen Youssef-El Soud, Paul Baas, Jos A. Stigt, Nico van Walree, Harry J.M. Groen, Harm van Tinteren, Ferry Lalezari, Nvalt Study Team, Robbert C. van Heemst, Jacobus A. Burgers, Wieneke A. Buikhuisen, Cornedine J. de Gooijer, Agnes J. Staal-van den Brekel, Bonne Biesma, Joachim G.J.V. Aerts, Vincent van der Noort, Gerben Bootsma, Floris Dammeijer, Robin Cornelissen
Publikováno v:
SSRN Electronic Journal.
Background: All patients with malignant mesothelioma develop progressive disease after first line therapy. Some studies have addressed maintenance therapy, none showed a great impact. Gemcitabine, an active drug in mesothelioma, was tested in the NVA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e7f7e7d9fa2908b5b66340540efb393
https://doi.org/10.2139/ssrn.3520057
https://doi.org/10.2139/ssrn.3520057
Autor:
Gerarda J.M. Herder, Agnes J. Staal-van den Brekel, Joachim G.J.V. Aerts, Anne-Marie C. Dingemans, Tjeerd Haitjema, Michel M. van den Heuvel, Lizza E.L. Hendriks, Egbert F. Smit, Ben E. E. M. van den Borne, A. Termeer, Martijn J. Goosens, Lucie Masen-Poos, Robbert C. van Heemst, Frans H. Krouwels, Jos A. Stigt, E. Pouw, Wouter W. Mellema, Hans J.M. Smit, Anthonie J. van der Wekken
Publikováno v:
Lung Cancer, 90(2), 249-254. Elsevier Ireland Ltd
Lung Cancer, 90(2), 249-254. ELSEVIER IRELAND LTD
Mellema, W W, Masen-Poos, L, Smit, E F, Hendriks, L E L, Aerts, JG, Termeer, A, Goosens, M J, Smit, H J M, van den Heuvel, M M, van der Wekken, A J, Herder, G J M, Krouwels, F H, Stigt, J A, van den Borne, B E E M, Haitjema, T J, Staal-Van Den Brekel, A, van Heemst, R C, Pouwq, E & Dingemans, A M C 2015, ' Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer ', Lung Cancer, vol. 90, no. 2, pp. 249-254 . https://doi.org/10.1016/j.lungcan.2015.09.012
Lung Cancer, 90(2), 249-254. ELSEVIER IRELAND LTD
Mellema, W W, Masen-Poos, L, Smit, E F, Hendriks, L E L, Aerts, JG, Termeer, A, Goosens, M J, Smit, H J M, van den Heuvel, M M, van der Wekken, A J, Herder, G J M, Krouwels, F H, Stigt, J A, van den Borne, B E E M, Haitjema, T J, Staal-Van Den Brekel, A, van Heemst, R C, Pouwq, E & Dingemans, A M C 2015, ' Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer ', Lung Cancer, vol. 90, no. 2, pp. 249-254 . https://doi.org/10.1016/j.lungcan.2015.09.012
Objectives: As suggested by in-vitro data, we hypothesize that subtypes of ICRAS mutated non-small cell lung cancer (NSCLC) respond differently to chemotherapy regimens.Methods: Patients with advanced NSCLC and known KRAS mutation, treated with first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1fdfbe6a52fbb09bb6db5676889a236
https://research.vumc.nl/en/publications/84cfc5c1-2095-483b-a182-e57eb74efbfb
https://research.vumc.nl/en/publications/84cfc5c1-2095-483b-a182-e57eb74efbfb
Publikováno v:
Cancer, 79(4), 717-723. Wiley
BACKGROUND The purpose of this study was to investigate whether surgical removal of a tumor influences energy balance, body weight, and body composition in lung carcinoma patients. METHODS In 53 nonsmall cell lung carcinoma (NSCLC) patients, resting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5d70dda7b55207aa365137e57222d8
https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<717::aid-cncr8>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<717::aid-cncr8>3.0.co